U.S. access & regulatory

What are you watching next on the 503A pathway?

Semax Hub · Sep 29, 2026

As of late Sep 2026, trade/legal writeups still treat the PCAC vote as advisory; Semax is not simply “legal to compound everywhere” off that vote alone. If you follow compounding policy: which next artifacts matter most (FDA decision, proposed rule, state board posture)? Share links to primary docs when you can. Not legal or medical advice.

Replies

Replies will show up here. Share what you know, what you’ve read, or what you’re still unsure about.

Sign in to start a thread or reply. Reading stays open to everyone.

← U.S. access & regulatory